跳至主要内容
临床试验/EUCTR2018-001945-14-FI
EUCTR2018-001945-14-FI进行中(未招募)1 期

Investigation of safety and efficacy of NNC0174-0833 for weight management – a dose finding trial

ovo Nordisk A/S0 个研究点目标入组 700 人开始时间: 2018年11月9日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age greater than or equal to 18 years at the time of signing the informed consent
  • - Female subject of non-childbearing potential or Male subject who is surgically sterilised (vasectomy) or who is willing to use adequate contraceptive methods (as required by local regulation or practice) throughout the trial (until ‘end of trial’)
  • - Body mass index (BMI) greater than or equal to 30.0 kg/m^2 or BMI greater than or equal to 27.0 kg/m^2 with the presence of at least one of the following weight-related comorbidities (treated or untreated): hypertension or dyslipidaemia (to be assessed at the investigator’s discretion)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 650
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • - Glycated haemoglobin (HbA1c) greater than or equal to 48 mmol/mol (6.5%) as measured by the central laboratory at screening
  • - A self-reported change in body weight greater than 5 kg (11 lbs) within 90 days prior to screening irrespective of medical records

研究者

相似试验